Remote interactive evaluations: FDA official discusses lessons learned

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)ComplianceNorth AmericaOTCPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy